$VIR
Vir Biotechnology, Inc. Stock $vir

$vir Overview Financials Valuation SEC Filings Company Website

2020 Q1 Form 10-K Financial Statement

#000156459020013194 Filed on March 26, 2020

Income Statement

Concept	2020 Q1	2019 Q4	2018 Q4
Revenue	$5.718M	$980.0K	$3.126M
YoY Change	56.19%	-68.65%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$12.65M	$11.81M	$7.950M
YoY Change	47.78%	48.55%
% of Gross Profit
Research & Development	$64.98M	$52.93M	$21.97M
YoY Change	151.16%	140.92%
% of Gross Profit
Depreciation & Amortization	$1.000M	$1.150M	$900.0K
YoY Change	42.86%	27.78%
% of Gross Profit
Operating Expenses	$77.63M	$64.74M	$29.92M
YoY Change	125.46%	116.36%
Operating Profit	-$71.91M
YoY Change	133.7%
Interest Expense	$1.760M	$1.950M	$620.0K
YoY Change	-21.78%	214.52%
% of Operating Profit
Other Income/Expense, Net	-$5.314M	-$1.810M	-$200.0K
YoY Change	-353.05%	805.0%
Pretax Income	-$77.22M	-$63.62M	-$26.37M
YoY Change	169.35%	141.26%
Income Tax	$16.00K	$150.0K	$20.00K
% Of Pretax Income
Net Earnings	-$77.24M	-$63.77M	-$26.39M
YoY Change	169.41%	141.62%
Net Earnings / Revenue	-1350.82%	-6507.24%	-844.31%
Basic Earnings Per Share	-$0.71	-$0.69
Diluted Earnings Per Share	-$0.71	-$0.71	-$241.2K
COMMON SHARES
Basic Shares Outstanding	109.8M
Diluted Shares Outstanding

Balance Sheet

Concept	2020 Q1	2019 Q4	2018 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$355.6M	$383.4M
YoY Change
Cash & Equivalents	$168.4M	$109.3M	$47.60M
Short-Term Investments	$187.2M	$274.1M
Other Short-Term Assets	$21.90M	$19.60M
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$377.5M	$403.0M
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment	$16.24M	$16.31M	$12.29M
YoY Change		32.69%
Goodwill		$16.94M
YoY Change
Intangibles		$35.69M
YoY Change
Long-Term Investments	$6.100M	$24.30M
YoY Change
Other Assets	$8.900M	$15.80M
YoY Change
Total Long-Term Assets	$99.60M	$109.1M
YoY Change
TOTAL ASSETS
Total Short-Term Assets	$377.5M	$403.0M
Total Long-Term Assets	$99.60M	$109.1M
Total Assets	$477.1M	$512.1M	$191.6M
YoY Change		167.27%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$18.80M	$5.881M	$6.473M
YoY Change		-9.15%
Accrued Expenses	$21.70M	$26.50M	$14.53M
YoY Change		82.3%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$200.0K	$200.0K
YoY Change
Total Short-Term Liabilities	$56.40M	$59.21M	$39.91M
YoY Change		48.36%
LONG-TERM LIABILITIES
Long-Term Debt	$800.0K	$900.0K
YoY Change
Other Long-Term Liabilities	$36.30M	$3.568M	$1.588M
YoY Change		124.69%
Total Long-Term Liabilities	$37.10M	$3.568M	$1.588M
YoY Change		124.69%
TOTAL LIABILITIES
Total Short-Term Liabilities	$56.40M	$59.21M	$39.91M
Total Long-Term Liabilities	$37.10M	$3.568M	$1.588M
Total Liabilities	$96.80M	$88.13M	$61.64M
YoY Change		42.98%
SHAREHOLDERS EQUITY
Retained Earnings	-$445.8M	-$368.5M	-$193.8M
YoY Change		90.12%
Common Stock		$11.00K	$1.000K
YoY Change		1000.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$380.3M	$423.9M	-$179.2M
YoY Change
Total Liabilities & Shareholders Equity	$477.1M	$512.1M	$191.6M
YoY Change		167.27%

Cashflow Statement

Concept	2020 Q1	2019 Q4	2018 Q4
OPERATING ACTIVITIES
Net Income	-$77.24M	-$63.77M	-$26.39M
YoY Change	169.41%	141.62%
Depreciation, Depletion And Amortization	$1.000M	$1.150M	$900.0K
YoY Change	42.86%	27.78%
Cash From Operating Activities	-$48.41M	-$38.88M	-$29.51M
YoY Change	64.16%	31.75%
INVESTING ACTIVITIES
Capital Expenditures	$1.302M	-$1.550M	-$2.810M
YoY Change	-62.54%	-44.84%
Acquisitions
YoY Change
Other Investing Activities	$105.5M	-$72.22M	$18.90M
YoY Change	-138.98%	-482.12%
Cash From Investing Activities	$104.2M	-$73.77M	$16.10M
YoY Change	-138.01%	-558.2%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	85.00K	130.1M	10.44M
YoY Change	-99.97%	1146.17%
NET CHANGE
Cash From Operating Activities	-48.41M	-38.88M	-29.51M
Cash From Investing Activities	104.2M	-73.77M	16.10M
Cash From Financing Activities	85.00K	130.1M	10.44M
Net Change In Cash	55.90M	17.45M	-2.970M
YoY Change	306.33%	-687.54%
FREE CASH FLOW
Cash From Operating Activities	-$48.41M	-$38.88M	-$29.51M
Capital Expenditures	$1.302M	-$1.550M	-$2.810M
Free Cash Flow	-$49.71M	-$37.33M	-$26.70M
YoY Change	50.8%	39.81%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2019Q4	us-gaap	Long Term Investments LongTermInvestments	24290000
CY2019Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	12449000
CY2018Q4	us-gaap	Liabilities Current LiabilitiesCurrent	39908000
CY2018Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	6561000
CY2019Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	3305000
CY2018Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	3305000
CY2019Q4	us-gaap	Liabilities Liabilities	88129000
CY2019Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2018Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2019Q4	us-gaap	Preferred Stock Value PreferredStockValue
CY2019Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	5881000
CY2018Q4	us-gaap	Other Assets OtherAssets	6666000
CY2018Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	8761000
CY2019Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	13378000
CY2019Q4	us-gaap	Assets Assets	512071000
CY2018Q4	us-gaap	Assets Assets	191596000
CY2018Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	6473000
CY2019Q4	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	8200000
CY2019Q4	us-gaap	Assets Current AssetsCurrent	402995000
CY2019Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	35694000
CY2019Q4	us-gaap	Goodwill Goodwill	16937000
CY2019Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	16308000
CY2018Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	1003000
CY2019Q4	us-gaap	Other Assets OtherAssets	8547000
CY2018Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1588000
CY2018Q4	us-gaap	Liabilities Liabilities	61636000
CY2019Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-368519000
CY2019Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	3568000
CY2019Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-601000
CY2019Q4	us-gaap	Common Stock Value CommonStockValue	11000
CY2019Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	793051000
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	423942000
CY2018Q4	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	9250000
CY2019Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	512071000
CY2019Q4	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	9380000
CY2020Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	109799589
CY2019Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	7300000
CY2019	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2019Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	6181000
CY2019Q4	us-gaap	Liabilities Current LiabilitiesCurrent	59206000
CY2019Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	12670000
CY2017	us-gaap	Net Income Loss NetIncomeLoss	-69852000
CY2019	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-5.76
CY2018	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-15.12
CY2018	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	7666463
CY2017	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	2152273
CY2018	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-116364000
CY2019	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-5061000
CY2017	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-80776000
CY2017	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-32.45
CY2017	us-gaap	Net Income Loss NetIncomeLoss	-69852000
CY2019	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	3450000
CY2018	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-480000
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-174529000
CY2017	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-10924000
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	154000
CY2018	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	2328000
CY2019	us-gaap	Investment Income Interest InvestmentIncomeInterest	8511000
CY2018	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-212000
CY2017	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	721000
CY2018Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	10761000
CY2018Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	1003000
CY2017Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	1003000
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	122816000
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	59362000
CY2019Q3	us-gaap	Stockholders Equity Note Stock Split Conversion Ratio1 StockholdersEquityNoteStockSplitConversionRatio1	0.222222222
CY2019	us-gaap	Lessee Operating Lease Existence Of Option To Extend LesseeOperatingLeaseExistenceOfOptionToExtend	true
CY2019Q3	us-gaap	Lessee Finance Lease Term Of Contract1 LesseeFinanceLeaseTermOfContract1	P5Y
CY2018	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	0.865
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	0.864
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	0.865
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	0.894
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	0.880
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	0.873
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.015
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.025
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.014
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.025
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.030
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.022
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	109335000
CY2019Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	274101000
CY2019Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	6181000
CY2019Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	26495000
CY2018Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	14534000
CY2018Q4	vir	Advanced Proceeds From Preferred Stock Financing AdvancedProceedsFromPreferredStockFinancing	10140000
CY2018Q4	vir	Convertible Preferred Stock Warrant Liability ConvertiblePreferredStockWarrantLiability	1024000
CY2019Q4	us-gaap	Temporary Equity Par Or Stated Value Per Share TemporaryEquityParOrStatedValuePerShare	0.0001
CY2018Q4	us-gaap	Temporary Equity Par Or Stated Value Per Share TemporaryEquityParOrStatedValuePerShare	0.0001
CY2019Q4	us-gaap	Temporary Equity Shares Authorized TemporaryEquitySharesAuthorized	0
CY2019Q4	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	0
CY2018Q4	us-gaap	Temporary Equity Shares Authorized TemporaryEquitySharesAuthorized	421450000
CY2019Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	0
CY2018Q4	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	69910520
CY2018Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	69910520
CY2019Q4	us-gaap	Temporary Equity Liquidation Preference TemporaryEquityLiquidationPreference	0
CY2018Q4	us-gaap	Temporary Equity Liquidation Preference TemporaryEquityLiquidationPreference	333058000
CY2018Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	309137000
CY2019Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2018Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2019Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000
CY2018Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	0
CY2019Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2018Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2019Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2018Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2019Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2018Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2019Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000
CY2018Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	558350000
CY2019Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	107648925
CY2019Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	107648925
CY2018Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	8858799
CY2018Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	8858799
CY2019	us-gaap	Revenues Revenues	8091000
CY2018	us-gaap	Revenues Revenues	10668000
CY2017	us-gaap	Revenues Revenues	2708000
CY2019	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	148472000
CY2018	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	100229000
CY2017	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	62512000
CY2019	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	37598000
CY2018	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	29131000
CY2017	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	21693000
CY2019	us-gaap	Operating Expenses OperatingExpenses	186070000
CY2018	us-gaap	Operating Expenses OperatingExpenses	129360000
CY2017	us-gaap	Operating Expenses OperatingExpenses	84205000
CY2019	us-gaap	Operating Income Loss OperatingIncomeLoss	-177979000
CY2018	us-gaap	Operating Income Loss OperatingIncomeLoss	-118692000
CY2017	us-gaap	Operating Income Loss OperatingIncomeLoss	-81497000
CY2018	us-gaap	Investment Income Interest InvestmentIncomeInterest	2540000
CY2017	us-gaap	Investment Income Interest InvestmentIncomeInterest	638000
CY2017	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	83000
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-174683000
CY2019	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	30349920
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-174683000
CY2018	us-gaap	Net Income Loss NetIncomeLoss	-115884000
CY2019	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	149000
CY2018	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-14000
CY2019	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	736000
CY2019	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-587000
CY2018	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-14000
CY2019	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-175270000
CY2018	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-115898000
CY2017	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-69852000
CY2016Q4	us-gaap	Stockholders Equity StockholdersEquity	-7972000
CY2017	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	2475000
CY2017	vir	Stock Issued During Period Value Acquisitions Of Research And Development StockIssuedDuringPeriodValueAcquisitionsOfResearchAndDevelopment	1651000
CY2017	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	4782000
CY2017Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	65944430
CY2017Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	292525000
CY2017Q4	us-gaap	Stockholders Equity StockholdersEquity	-68916000
CY2018	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	584000
CY2018	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	5053000
CY2018	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-14000
CY2018	us-gaap	Net Income Loss NetIncomeLoss	-115884000
CY2018Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	69910520
CY2018Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	309137000
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	-179177000
CY2019	vir	Temporary Equity Conversion Of Convertible Preferred Stock Into Common Stock Shares TemporaryEquityConversionOfConvertiblePreferredStockIntoCommonStockShares	88112733
CY2019	vir	Temporary Equity Conversion Of Convertible Preferred Stock Into Common Stock TemporaryEquityConversionOfConvertiblePreferredStockIntoCommonStock	636612000
CY2019	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	636612000
CY2019	vir	Initial Public Offering Costs InitialPublicOfferingCosts	16446000
CY2019	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	126411000
CY2019	vir	Reclassification Of Warrant Liability To Additional Paid In Capital ReclassificationOfWarrantLiabilityToAdditionalPaidInCapital	3073000
CY2019	us-gaap	Adjustments To Additional Paid In Capital Stock Split AdjustmentsToAdditionalPaidInCapitalStockSplit	3000
CY2019	vir	Stock Issued During Period Value License Agreement StockIssuedDuringPeriodValueLicenseAgreement	617000
CY2019	vir	Stock Issued During Period Repayment Of Promissory Notes Net Of Unvested Common Stock Value StockIssuedDuringPeriodRepaymentOfPromissoryNotesNetOfUnvestedCommonStockValue	1355000
CY2019	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	476000
CY2019	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1129000
CY2019	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	8719000
CY2019	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-587000
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-174683000
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	423942000
CY2019	us-gaap	Profit Loss ProfitLoss	-174683000
CY2018	us-gaap	Profit Loss ProfitLoss	-115884000
CY2017	us-gaap	Profit Loss ProfitLoss	-69852000
CY2019	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-345000
CY2018	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-198000
CY2019	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	3294000
CY2018	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1618000
CY2017	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	255000
CY2019	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1223000
CY2018	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1138000
CY2017	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	177000
CY2019	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	179000
CY2018	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	328000
CY2019	vir	Change In Estimated Fair Value Of Contingent Consideration ChangeInEstimatedFairValueOfContingentConsideration	8330000
CY2018	vir	Change In Estimated Fair Value Of Contingent Consideration ChangeInEstimatedFairValueOfContingentConsideration	250000
CY2017	vir	Change In Estimated Fair Value Of Contingent Consideration ChangeInEstimatedFairValueOfContingentConsideration	2750000
CY2019	vir	Initial Fair Value Of Derivative Liability InitialFairValueOfDerivativeLiability	13599000
CY2019	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	1150000
CY2019	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	2049000
CY2018	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	95000
CY2017	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-82000
CY2018	vir	Preferred Stock Issued In Connection With Asset Acquisition PreferredStockIssuedInConnectionWithAssetAcquisition	1750000
CY2019	vir	Common Stock Issued In Connection With License Agreement CommonStockIssuedInConnectionWithLicenseAgreement	617000
CY2017	vir	Common Stock Issued In Connection With License Agreement CommonStockIssuedInConnectionWithLicenseAgreement	1651000
CY2018	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	480000
CY2019	us-gaap	Proceeds From Issuance Of Convertible Preferred Stock ProceedsFromIssuanceOfConvertiblePreferredStock	317335000
CY2018	us-gaap	Proceeds From Issuance Of Convertible Preferred Stock ProceedsFromIssuanceOfConvertiblePreferredStock	14254000
CY2017	us-gaap	Proceeds From Issuance Of Convertible Preferred Stock ProceedsFromIssuanceOfConvertiblePreferredStock	271182000
CY2019	vir	Failed Sale Leaseback Transaction Proceeds Financing Activities FailedSaleLeasebackTransactionProceedsFinancingActivities	1202000
CY2019	vir	Cash Paid In Lieu Of Fractional Shares In Reverse Split Of Common Stock CashPaidInLieuOfFractionalSharesInReverseSplitOfCommonStock	3000
CY2019	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	95000
CY2017	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	10924000
CY2019	us-gaap	Share Based Compensation ShareBasedCompensation	8719000
CY2018	us-gaap	Share Based Compensation ShareBasedCompensation	5053000
CY2017	us-gaap	Share Based Compensation ShareBasedCompensation	4782000
CY2019	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	4619000
CY2018	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	4172000
CY2017	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	2600000
CY2019	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	1881000
CY2018	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-151000
CY2017	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	246000
CY2019	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	964000
CY2018	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1471000
CY2017	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	2011000
CY2019	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	10211000
CY2018	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	7171000
CY2017	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	4809000
CY2019	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	3529000
CY2018	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	7873000
CY2017	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	888000
CY2019	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-129632000
CY2018	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-94096000
CY2017	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-66381000
CY2019	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	8940000
CY2018	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	8192000
CY2017	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2742000
CY2019	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	643898000
CY2018	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	123105000
CY2019	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	396680000
CY2018	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	72574000
CY2018	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	25000
CY2018	us-gaap	Payments To Acquire Assets Investing Activities PaymentsToAcquireAssetsInvestingActivities	1743000
CY2017	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	27252000
CY2019	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-256158000
CY2018	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-60441000
CY2017	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-29994000
CY2019	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	126411000
CY2019	vir	Proceeds From Repayment Of Promissory Notes ProceedsFromRepaymentOfPromissoryNotes	3265000
CY2019	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	1129000
CY2018	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	584000
CY2018	vir	Advanced Proceeds From Convertible Preferred Stock Financing AdvancedProceedsFromConvertiblePreferredStockFinancing	10140000
CY2019	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	449244000
CY2018	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	24978000
CY2017	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	271182000
CY2019	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	63454000
CY2018	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-129559000
CY2017	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	174807000
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	59362000
CY2017Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	188921000
CY2016Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	14114000
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	122816000
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	59362000
CY2017Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	188921000
CY2017	us-gaap	Stock Issued1 StockIssued1	2475000
CY2017	vir	Contingent Consideration Recorded In Connection With Business Acquisitions ContingentConsiderationRecordedInConnectionWithBusinessAcquisitions	6250000
CY2019	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	892000
CY2018	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	1996000
CY2017	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	1885000
CY2017	vir	Issuance Costs For Convertible Preferred Stock In Accounts Payable And Accrued Liabilities IssuanceCostsForConvertiblePreferredStockInAccountsPayableAndAccruedLiabilities	15000
CY2017	vir	Receipt Of Promissory Note From Related Parties For Purchase Of Common Stock ReceiptOfPromissoryNoteFromRelatedPartiesForPurchaseOfCommonStock	3159000
CY2018	us-gaap	Noncash Or Part Noncash Acquisition Value Of Assets Acquired1 NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1	593000
CY2019	vir	Conversion Of Preferred Stock Into Common Stock Upon Completion Of Initial Public Offering ConversionOfPreferredStockIntoCommonStockUponCompletionOfInitialPublicOffering	636612000
CY2019	vir	Reclassification Of Preferred Stock Warrant Liability To Additional Paid In Capital ReclassificationOfPreferredStockWarrantLiabilityToAdditionalPaidInCapital	3073000
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	109335000
CY2018Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	47598000
CY2017Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	187918000
CY2019Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	6181000
CY2019Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	7300000
CY2017Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	188921000
CY2019	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	On September 16, 2019, the Company’s board of directors approved an amendment to the Company’s amended and restated certificate of incorporation to effect a 1-for-4.5 reverse split (“Reverse Split”) of shares of the Company’s common and convertible preferred stock, which was effected on September 27, 2019.
CY2019Q4	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	126400000
CY2019Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-368500000
CY2019Q4	vir	Cash And Cash Equivalents And Investments CashAndCashEquivalentsAndInvestments	407700000
CY2019	us-gaap	Use Of Estimates UseOfEstimates	<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Use of Estimates </p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of the consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expense during the reporting periods. The Company evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors and adjusts those estimates and assumptions when facts and circumstances dictate. Actual results could materially differ from those estimates. </p>
CY2019	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1
CY2019	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Concentration of Credit Risk </p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash and cash equivalents and short and long-term investments. Cash and cash equivalents are deposited in checking and sweep accounts at a financial institution. Such deposits may, at times, exceed federally insured limits. The Company has not experienced any losses on its deposits of cash and cash equivalents. </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company’s investment policy limits investments to certain types of securities issued by the U.S. government, its agencies and institutions with investment-grade credit ratings and places restrictions on maturities and concentration by type and issuer. The Company is exposed to credit risk in the event of a default by the financial institutions holding its cash, cash equivalents and investments, and issuers of the investments to the extent recorded on the consolidated balance sheets. As of December 31, 2019, the Company has no off-balance sheet concentrations of credit risk. </p>
CY2019	us-gaap	Property Plant And Equipment Estimated Useful Lives PropertyPlantAndEquipmentEstimatedUsefulLives	Depreciation and amortization are computed using the straight-line method over the estimated useful lives of the respective assets, generally three to five years.
CY2019	us-gaap	Impairment Of Intangible Assets Indefinitelived Excluding Goodwill ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill	0
CY2019	us-gaap	Finite Lived Intangible Assets Amortization Method FiniteLivedIntangibleAssetsAmortizationMethod	Amortization is computed using the straight-line method over the estimated useful lives of the respective finite-lived intangible assets, generally three to twelve years.
CY2019	us-gaap	Derivatives Embedded Derivatives DerivativesEmbeddedDerivatives	<p id="T0" style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company evaluates certain of its financial and business development transactions to determine if embedded components of these contracts meet the definition of a derivative under Topic ASC 815, “<span style="font-style:italic;">Derivatives and Hedging</span>”. In general, embedded derivatives are required to be bifurcated from the host instrument if (i) the embedded feature is not clearly and closely related to the host contract and (ii) the embedded feature, if considered a freestanding instrument, meets the definition of a derivative. The embedded derivatives are reported on the consolidated balance sheets at their estimated fair values. Any change in estimated fair values, as determined at each measurement period, are recorded in the consolidated statements of operations.</p>
CY2019Q4	vir	Embedded Derivative Initial Fair Value Of Embedded Derivative Liability EmbeddedDerivativeInitialFairValueOfEmbeddedDerivativeLiability	13600000
CY2019Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	12400000
CY2019Q4	vir	Financial Assets Amortized Cost Basis FinancialAssetsAmortizedCostBasis	406883000
CY2019Q4	vir	Financial Assets Gross Unrealized Holding Gains FinancialAssetsGrossUnrealizedHoldingGains	140000
CY2019Q4	vir	Financial Assets Gross Unrealized Holding Losses FinancialAssetsGrossUnrealizedHoldingLosses	5000
CY2019Q4	vir	Financial Assets Fair Value FinancialAssetsFairValue	407018000
CY2019Q4	vir	Financial Liabilities Amortized Cost Basis FinancialLiabilitiesAmortizedCostBasis	30029000
CY2019Q4	vir	Financial Liabilities Fair Value FinancialLiabilitiesFairValue	30029000
CY2018Q4	vir	Financial Assets Amortized Cost Basis FinancialAssetsAmortizedCostBasis	94459000
CY2018Q4	vir	Financial Assets Gross Unrealized Holding Losses FinancialAssetsGrossUnrealizedHoldingLosses	14000
CY2018Q4	vir	Financial Liabilities Amortized Cost Basis FinancialLiabilitiesAmortizedCostBasis	10274000
CY2018Q4	vir	Financial Liabilities Fair Value FinancialLiabilitiesFairValue	10274000
CY2019	us-gaap	Debt Securities Available For Sale Unrealized Gain Loss DebtSecuritiesAvailableForSaleUnrealizedGainLoss	100000
CY2018	us-gaap	Debt Securities Available For Sale Unrealized Gain Loss DebtSecuritiesAvailableForSaleUnrealizedGainLoss	-14000
CY2019	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0
CY2019Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	1223000
CY2019Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	584000
CY2019Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	499000
CY2019Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	499000
CY2019Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	226000
CY2019Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	3031000
CY2018	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	0
CY2019	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	0
CY2019Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	21140000
CY2018Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	14006000
CY2019Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	4832000
CY2018Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1716000
CY2019Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	16308000
CY2018Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	12290000
CY2019	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	3300000
CY2018	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1600000
CY2017	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	300000
CY2019Q3	vir	Sale Leaseback Transaction Proceeds From Financing Obligations SaleLeasebackTransactionProceedsFromFinancingObligations	1200000
CY2019Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	200000
CY2019Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	900000
CY2019Q4	vir	Payroll And Related Expenses Current PayrollAndRelatedExpensesCurrent	9410000
CY2018Q4	vir	Payroll And Related Expenses Current PayrollAndRelatedExpensesCurrent	6165000
CY2019Q4	vir	Research And Development Expenses Current ResearchAndDevelopmentExpensesCurrent	12530000
CY2018Q4	vir	Research And Development Expenses Current ResearchAndDevelopmentExpensesCurrent	5016000
CY2019Q4	vir	Restricted Stock Liability Current RestrictedStockLiabilityCurrent	1434000
CY2019Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	237000
CY2019Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	1634000
CY2018Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	694000
CY2019Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1250000
CY2018Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	2659000
CY2019Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	26495000
CY2018Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	14534000
CY2019	vir	Lease Arrangement Contractual Expiration Beginning Year LeaseArrangementContractualExpirationBeginningYear	2020
CY2019	vir	Lease Arrangement Contractual Expiration Ending Year LeaseArrangementContractualExpirationEndingYear	2028
CY2019	us-gaap	Lessee Operating Lease Option To Extend LesseeOperatingLeaseOptionToExtend	The lease agreements also provide the Company with the option to renew for additional periods ranging from one to five years
CY2019Q4	vir	Lessee Operating And Finance Lease Liability Payments Due Next Twelve Months LesseeOperatingAndFinanceLeaseLiabilityPaymentsDueNextTwelveMonths	4525000
CY2019Q4	vir	Lessee Operating And Finance Lease Liability Payments Due Year Two LesseeOperatingAndFinanceLeaseLiabilityPaymentsDueYearTwo	4145000
CY2019Q4	vir	Lessee Operating And Finance Lease Liability Payments Due Year Three LesseeOperatingAndFinanceLeaseLiabilityPaymentsDueYearThree	4206000
CY2019Q4	vir	Lessee Operating And Finance Lease Liability Payments Due Year Four LesseeOperatingAndFinanceLeaseLiabilityPaymentsDueYearFour	4250000
CY2019Q4	vir	Lessee Operating And Finance Lease Liability Payments Due Year Four And Thereafter LesseeOperatingAndFinanceLeaseLiabilityPaymentsDueYearFourAndThereafter	4005000
CY2019Q4	vir	Lessee Operating And Finance Lease Liability Payments Due LesseeOperatingAndFinanceLeaseLiabilityPaymentsDue	21131000
CY2019	vir	Operating And Finance Rent Expense OperatingAndFinanceRentExpense	4400000
CY2018	vir	Operating And Finance Rent Expense OperatingAndFinanceRentExpense	4000000.0
CY2017	vir	Operating And Finance Rent Expense OperatingAndFinanceRentExpense	2600000
CY2018Q4	us-gaap	Temporary Equity Shares Authorized TemporaryEquitySharesAuthorized	421450000
CY2018Q4	vir	Temporary Equity Shares Issued And Outstanding TemporaryEquitySharesIssuedAndOutstanding	69910520
CY2018Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	309137000
CY2018Q4	us-gaap	Temporary Equity Liquidation Preference TemporaryEquityLiquidationPreference	333058000
CY2019	us-gaap	Convertible Preferred Stock Terms Of Conversion ConvertiblePreferredStockTermsOfConversion	Each share of Series A-1 convertible preferred stock, Series A-2 convertible preferred stock and Series B convertible preferred stock was convertible, at the option of the holder, into one share of common stock, subject to certain adjustments for dilution, if any, resulting from future stock issuances.
CY2016Q3	us-gaap	Class Of Warrant Or Righst Date From Which Warrants Or Rights Exercisable ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable	2026-09-11
CY2016Q3	us-gaap	Warrants And Rights Outstanding Term WarrantsAndRightsOutstandingTerm	P10Y
CY2018Q4	vir	Convertible Preferred Stock Warrant Liability ConvertiblePreferredStockWarrantLiability	1000000.0
CY2019	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	8719000
CY2018	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	5053000
CY2017	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	4782000
CY2019	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	9506253
CY2018	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	80014621
CY2017	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	75730421
CY2019	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	1200000
CY2018	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	700000
CY2017	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	200000
CY2019	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	154000
CY2018	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	20000
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-138724000
CY2018	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-110399000
CY2017	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-77947000
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-35805000
CY2018	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-5965000
CY2017	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-2829000
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-174529000
CY2018	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-116364000
CY2017	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-80776000
CY2019	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	154000
CY2017	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.050
CY2018	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	20000
CY2018	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-445000
CY2017	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-10924000
CY2018	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-55000
CY2018	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-500000
CY2017	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-10924000
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	154000
CY2018	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-480000
CY2017	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-10924000
CY2019	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2018	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2017	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.340
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	-0.003
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	-0.001
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	-0.005
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Tax Cuts And Jobs Act Of2017 Percent EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent	-6.8
CY2019	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.024
CY2018	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.020
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	0.020
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	0.022
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	0.010
CY2018	vir	Effective Income Tax Rate Reconciliation In Process Research And Development Percent EffectiveIncomeTaxRateReconciliationInProcessResearchAndDevelopmentPercent	-0.029
CY2019	vir	Effective Income Tax Rate Reconciliation Permanent Items Percent EffectiveIncomeTaxRateReconciliationPermanentItemsPercent	-0.008
CY2018	vir	Effective Income Tax Rate Reconciliation Permanent Items Percent EffectiveIncomeTaxRateReconciliationPermanentItemsPercent	-0.004
CY2017	vir	Effective Income Tax Rate Reconciliation Permanent Items Percent EffectiveIncomeTaxRateReconciliationPermanentItemsPercent	-0.001
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.243
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.214
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.190
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.001
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.001
CY2019	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.001
CY2018	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.004
CY2017	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.135
CY2019Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	67493000
CY2018Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	36358000
CY2019Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	6978000
CY2018Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	3357000
CY2019Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	8502000
CY2018Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	1331000
CY2019Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	8180000
CY2018Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	7761000
CY2019Q4	vir	Deferred Tax Liabilities In Process Research And Development DeferredTaxLiabilitiesInProcessResearchAndDevelopment	8647000
CY2018Q4	vir	Deferred Tax Liabilities In Process Research And Development DeferredTaxLiabilitiesInProcessResearchAndDevelopment	8647000
CY2019Q4	vir	Deferred Tax Assets Liabilities Before Valuation Allowance DeferredTaxAssetsLiabilitiesBeforeValuationAllowance	82506000
CY2018Q4	vir	Deferred Tax Assets Liabilities Before Valuation Allowance DeferredTaxAssetsLiabilitiesBeforeValuationAllowance	40160000
CY2019Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	85811000
CY2018Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	43465000
CY2019Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	3305000
CY2018Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	3305000
CY2019	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	42300000
CY2018	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	26000000.0
CY2017	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	15800000
CY2019Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	2700000
CY2018	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	215000
CY2019	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	1784000
CY2019Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	0
CY2019	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	0
CY2018	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	0
CY2019Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0
CY2017	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	0
CY2018Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	2404000
CY2017Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	272000
CY2016Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	19000
CY2019	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	133000
CY2018	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	32000
CY2019	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	1596000
CY2018	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	2315000
CY2017	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	253000
CY2019Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	2725000
CY2018Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	2404000
CY2017Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	272000
CY2019Q1	us-gaap	Revenues Revenues	3661000
CY2019Q2	us-gaap	Revenues Revenues	2047000
CY2019Q3	us-gaap	Revenues Revenues	1403000
CY2019Q4	us-gaap	Revenues Revenues	980000
CY2019Q1	us-gaap	Operating Expenses OperatingExpenses	34431000
CY2019Q2	us-gaap	Operating Expenses OperatingExpenses	37817000
CY2019Q3	us-gaap	Operating Expenses OperatingExpenses	49083000
CY2019Q4	us-gaap	Operating Expenses OperatingExpenses	64739000
CY2019Q1	us-gaap	Net Income Loss NetIncomeLoss	-28670000
CY2019Q2	us-gaap	Net Income Loss NetIncomeLoss	-33928000
CY2019Q3	us-gaap	Net Income Loss NetIncomeLoss	-48314000
CY2019Q4	us-gaap	Net Income Loss NetIncomeLoss	-63771000
CY2019Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-3.19
CY2019Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-3.64
CY2019Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-4.60
CY2019Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.69
CY2019Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-3.19
CY2019Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-3.64
CY2019Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-4.60
CY2019Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.71
CY2018Q1	us-gaap	Revenues Revenues	2433000
CY2018Q2	us-gaap	Net Income Loss NetIncomeLoss	-24446000
CY2018Q2	us-gaap	Revenues Revenues	2224000
CY2018Q3	us-gaap	Revenues Revenues	2885000
CY2018Q4	us-gaap	Revenues Revenues	3126000
CY2018Q1	us-gaap	Operating Expenses OperatingExpenses	34989000
CY2018Q2	us-gaap	Operating Expenses OperatingExpenses	27218000
CY2018Q3	us-gaap	Operating Expenses OperatingExpenses	37231000
CY2018Q4	us-gaap	Operating Expenses OperatingExpenses	29922000
CY2018Q1	us-gaap	Net Income Loss NetIncomeLoss	-31589000
CY2018Q3	us-gaap	Net Income Loss NetIncomeLoss	-33456000
CY2018Q4	us-gaap	Net Income Loss NetIncomeLoss	-26393000
CY2018Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-4.76
CY2018Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-3.35
CY2018Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-4.16
CY2018Q4	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-3.05

Files In Submission

Name	View Source	Status
0001564590-20-013194-index-headers.html	Edgar Link	pending
0001564590-20-013194-index.html	Edgar Link	pending
0001564590-20-013194.txt	Edgar Link	pending
0001564590-20-013194-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
gm25sedasnba000001.jpg	Edgar Link	pending
gm25sedasnba000002.jpg	Edgar Link	pending
gm25sedasnba000003.jpg	Edgar Link	pending
gm25sedasnba000004.jpg	Edgar Link	pending
gm25sedasnba000005.jpg	Edgar Link	pending
gm25sedasnba000006.jpg	Edgar Link	pending
gm25sedasnba000007.jpg	Edgar Link	pending
gm25sedasnba000008.jpg	Edgar Link	pending
gm25sedasnba000009.jpg	Edgar Link	pending
gm25sedasnba000010.jpg	Edgar Link	pending
gm25sedasnba000011.jpg	Edgar Link	pending
gm25sedasnba000012.jpg	Edgar Link	pending
gm25sedasnba000013.jpg	Edgar Link	pending
gm25sedasnba000014.jpg	Edgar Link	pending
gm25sedasnba000015.jpg	Edgar Link	pending
gm25sedasnba000016.jpg	Edgar Link	pending
gm25sedasnba000017.jpg	Edgar Link	pending
gm25sedasnba000018.jpg	Edgar Link	pending
gm25sedasnba000019.jpg	Edgar Link	pending
gm25sedasnba000020.jpg	Edgar Link	pending
gm25sedasnba000021.jpg	Edgar Link	pending
gpf0xrfpa0ia000001.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
vir-10k_20191231.htm	Edgar Link	pending
vir-10k_20191231_htm.xml	Edgar Link	completed
vir-20191231.xsd	Edgar Link	pending
vir-20191231_cal.xml	Edgar Link	unprocessable
vir-20191231_def.xml	Edgar Link	unprocessable
vir-20191231_lab.xml	Edgar Link	unprocessable
vir-20191231_pre.xml	Edgar Link	unprocessable
vir-ex1012_1068.htm	Edgar Link	pending
vir-ex1019_1067.htm	Edgar Link	pending
vir-ex1020_1312.htm	Edgar Link	pending
vir-ex1022_1066.htm	Edgar Link	pending
vir-ex1031_1064.htm	Edgar Link	pending
vir-ex1032_1065.htm	Edgar Link	pending
vir-ex1034_1063.htm	Edgar Link	pending
vir-ex1035_1062.htm	Edgar Link	pending
vir-ex231_1313.htm	Edgar Link	pending
vir-ex311_11.htm	Edgar Link	pending
vir-ex312_9.htm	Edgar Link	pending
vir-ex321_12.htm	Edgar Link	pending
vir-ex44_1069.htm	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$VIR
Vir Biotechnology, Inc. Stock $vir

2020 Q1 Form 10-K Financial Statement

#000156459020013194 Filed on March 26, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$VIR Vir Biotechnology, Inc. Stock $vir

2020 Q1 Form 10-K Financial Statement

#000156459020013194 Filed on March 26, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$VIR
Vir Biotechnology, Inc. Stock $vir